MRI强化比与斑块陡度或能更准确预测颅内动脉粥样硬化患者的复发性缺血性脑血管事件
本研究为回顾性队列研究,纳入80例因颅内动脉粥样硬化(ICAS)发生急性缺血事件并接受高分辨率多对比MRI(hrMRI)检查的患者,中位随访30个月。结果显示,强化比(HR 13.13,95%CI 3.58-48.20,p<0.001)和斑块陡度(斑块高度/长度,HR 110.27,95%CI 4.75-2560.91,p=0.003)是复发性缺血性脑血管事件的独立影像生物标志物;将二者整合入临床危险因素后,ROC曲线下面积从0.79提高至0.94(p=0.008)。
要点
- 强化比和斑块陡度(高度/长度)是预测ICAS患者复发性缺血事件的独立影像生物标志物。
- 将强化比和斑块陡度整合入临床危险因素可提高预测复发性事件的判别能力(ROC从0.79升至0.94)。
- 高分辨率MRI有助于临床评估高风险颅内斑块。
核心结论
- 强化比和斑块陡度在预测ICAS患者复发性缺血性脑血管事件方面,较传统临床危险因素提高了准确性。
研究设计与样本
- 回顾性队列研究,纳入80例2015年1月至2019年1月期间接受hrMRI检查的ICAS所致急性缺血事件患者,中位随访30个月(范围1至52个月)。
关键影像表现/征象
- 复发患者的ICAS斑块强化比显著高于未复发患者(p<0.001)。
- 复发患者的斑块陡度(斑块高度与长度之比)显著高于未复发患者(p=0.015)。
诊断标准与关键数值
- 强化比与复发性事件独立相关(HR 13.13,95%CI 3.58-48.20,p<0.001)。
- 斑块陡度(高度/长度)与复发性事件独立相关(HR 110.27,95%CI 4.75-2560.91,p=0.003)。
- 将强化比和斑块陡度整合入临床危险因素后,时间依赖ROC从0.79提高至0.94(p=0.008)。
临床应用与阅片要点
- 高分辨率MRI有助于临床评估高风险颅内斑块。
- 强化比和斑块陡度(高度/长度)是与未来缺血性脑血管事件相关的主要生物标志物。
- 高分辨率MRI联合临床特征对预测ICAS患者复发性事件显示出更高准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the complementary value of high-resolution multi-contrast MRI (hrMRI) in identifying symptomatic patients with intracranial atherosclerosis (ICAS) who are likely to experience recurrent ischemic cerebrovascular events.
METHODS: In this retrospective cohort study, eighty patients with acute ischemic events attributed to ICAS who underwent hrMRI examination between January 2015 and January 2019 were included. Median follow-up for all patients was 30 months (range: 1 to 52 months) and recurrent ischemic cerebrovascular events were recorded. Cox regression analysis and time-dependent ROC were performed to quantify the association between the plaque characteristics and recurrent events.
RESULTS: During the follow-up, 14 patients experienced recurrent ischemic cerebrovascular events. Young males and those with diabetes and poor medication persistence were more likely to experience recurrent events. ICAS in patients with recurrence had significantly higher enhancement ratio and steepness which is defined as the ratio between the plaque height and length than those without (p < 0.001 and p = 0.015, respectively). After adjustment of clinical factors, enhancement ratio (HR, 13.13 [95% CI, 3.58-48.20], p < 0.001) and plaque steepness (HR, 110.27 [95% CI, 4.75-2560.91], p = 0.003) were independent imaging biomarkers associated with recurrent events. Time-dependent ROC indicated that integrated high enhancement ratio and steepness into clinical risk factors improved discrimination power with the ROC increased from 0.79 to 0.94 (p = 0.008).
CONCLUSIONS: The enhancement ratio and plaque steepness improved the accuracy over traditional clinical risk factors in predicting recurrent ischemic cerebrovascular events for patients with ICAS.
KEY POINTS: • High-resolution magnetic resonance imaging helps clinicians to evaluate high-risk Intracranial plaque. • The higher enhancement ratio and plaque steepness (= height/length) were the primary biomarkers associated with future ischemic cerebrovascular events. • High-resolution magnetic resonance imaging combined with clinical characteristics showed a higher accuracy for the prediction of recurrent events in patients with intracranial atherosclerosis.
引用
- Yang D, Liu J, Yao W, et al. The MRI enhancement ratio and plaque steepness may be more accurate for predicting recurrent ischemic cerebrovascular events in patients with intracranial atherosclerosis. Eur Radiol. 2022. PMID: 35771249. doi:10.1007/s00330-022-08893-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。